Haemodynamic changes during sepsis;Hämodynamische veränderungen in der sepsis

Anasthesiologie und Intensivmedizin

Volumn 53, Issue 1, 2012, Pages 19-32

  Henrich, Michael ^a   Gruss M ^b   Weigand, M A ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b Klinikum Hanau GmbH   (Germany)

Author keywords

Circulation; Co 2 gap; Nitric oxide; Sepsis; Vasomotoricity

Indexed keywords

NITRIC OXIDE;

BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL PERMEABILITY; CARDIOMYOPATHY; CENTRAL VENOUS PRESSURE; DISEASE COURSE; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT MEASUREMENT; HEMODYNAMICS; HUMAN; HYPOTENSION; REVIEW; SEPSIS; SEPTIC SHOCK; SYSTOLIC BLOOD PRESSURE; TREATMENT PLANNING; VASCULAR RESISTANCE; VENOUS OXYGEN TENSION;

EID: 84856799854     PISSN: 01705334     EISSN: 14390256     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Sakr Y, et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004; 32(9):1825-31. (Pubitemid 39202356)
2. Rabuel C, Mebazaa A. Septic shock: a heart story since the 1960s. Intensive Care Med 2006;32(6):799-807. (Pubitemid 43781360)
3. Buwalda M, Ince C. Opening the microcirculation: can vasodilators be useful in sepsis? Intensive Care Med 2002;28(9):1208-1217. (Pubitemid 35025036)
4. Ince C, Sinaasappel M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 1999;27(7):1369-1377. (Pubitemid 29379377)
5. King CJ, et al. Ileal mucosal oxygen consumption is decreased in endotoxemic rats but is restored toward normal by treatment with aminoguanidine. Crit Care Med 1999;27(11):2518-2524.
6. Rosser DM, et al. Endotoxin reduces maximal oxygen consumption in hepatocytes independent of any hypoxic insult. Intensive Care Med 1998;24(7):725-729. (Pubitemid 28393406)
7. Waisbren BA. Bacteremia due to gramnegative bacilli other than the Salmonella; a clinical and therapeutic study. AMA Arch Intern Med 1951;88(4):467-488.
8. MacLean LD, et al. Patterns of septic shock in man - a detailed study of 56 patients. Ann Surg 1967;166(4):543-562.
9. Clowes GH Jr., Vucinic M, Weidner MG. Circulatory and metabolic alterations associated with survival or death in peritonitis: clinical analysis of 25 cases. Ann Surg 1966;163(6):866-885.
10. Gunnar RM, et al. Hemodynamic measurements in bacteremia and septic shock in man. J Infect Dis 1973;128:Suppl 295-298.
11. Winslow EJ, et al. Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am J Med 1973;54(4):421-432.
12. Krausz MM, et al. Cardiopulmonary effects of volume loading in patients in septic shock. Ann Surg 1977;185(4):429-434. (Pubitemid 8069869)
13. Parker MM, et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984;100(4):483-490. (Pubitemid 14126735)
14. Ellrodt AG, et al. Left ventricular performance in septic shock: reversible segmental and global abnormalities. Am Heart J 1985;110(2):402-409.
15. Natanson C, et al. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest 1989;83(1):243-251. (Pubitemid 19048430)
16. Natanson C, et al. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989;169(3):823-832. (Pubitemid 19085823)
17. Parker MM, et al. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990;97(1):126-131. (Pubitemid 20023505)
18. Poelaert J, et al. Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 1997;23(5):553-560. (Pubitemid 27263068)
19. Jardin F, et al. Persistent preload defect in severe sepsis despite fluid loading: A longitudinal echocardiographic study in patients with septic shock. Chest 1999;116(5):1354-1359. (Pubitemid 29535992)
20. Jones AE, et al. Diagnostic accuracy of left ventricular function for identifying sepsis among emergency department patients with nontraumatic symptomatic undifferentiated hypotension. Shock 2005;24(6):513-517.
21. Scheuren K, et al. Left ventricular end-diastolic area is a measure of cardiac preload in patients with early septic shock. Eur J Anaesthesiol 2009;26(9):759-765.
22. Cunnion RE, et al. The coronary circulation in human septic shock. Circulation 1986;73(4):637-644. (Pubitemid 16081421)
23. Dhainaut JF, et al. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 1987; 75(3):533-541.
24. Lanone S, et al. Muscular contractile failure in septic patients: role of the inducible nitric oxide synthase pathway. Am J Respir Crit Care Med 2000;162(6):2308-2315. (Pubitemid 32051705)
25. Groeneveld AB, et al. Maldistribution of heterogeneous coronary blood flow during canine endotoxin shock. Cardiovasc Res 1991;25(1):80-88.
26. Hotchkiss RS, et al. Evaluation of the role of cellular hypoxia in sepsis by the hypoxic marker [18F]fluoromisonidazole. Am J Physiol 1991;261(4 Pt 2):R965-972.
27. Yu P, et al. Myocardial collagen changes and edema in rats with hyperdynamic sepsis. Crit Care Med 1997;25(4):657-662. (Pubitemid 27193980)
28. Chagnon F, et al. Endotoxin-induced heart dysfunction in rats: assessment of myocardial perfusion and permeability and the role of fluid resuscitation. Crit Care Med 2006;34(1):127-133. (Pubitemid 43032389)
29. Finkel MS, et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257(5068):387-389.
30. Tavernier B, et al. Myofilament calcium sensitivity is decreased in skinned cardiac fibres of endotoxin-treated rabbits. Cardiovasc Res 1998;38(2):472-479. (Pubitemid 28294165)
31. Tavernier B, et al., Phosphorylation-dependent alteration in myofilament ca2+ sensitivity but normal mitochondrial function in septic heart. Am J Respir Crit Care Med 2001;163(2):362-367. (Pubitemid 32158513)
32. Lew WY, et al. Endotoxin-induced cardiac depression is associated with decreased cardiac dihydropyridine receptors in rabbits. J Mol Cell Cardiol 1996;28(6):1367-1371. (Pubitemid 26174428)
33. Annane D, et al. Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med 1999;160(2):458-465. (Pubitemid 29380658)
34. Korach M, et al. Cardiac variability in critically ill adults: influence of sepsis. Crit Care Med 2001;29(7):1380-1385. (Pubitemid 32641800)
35. Cryer HM, et al. Skeletal microcirculatory responses to hyperdynamic Escherichia coli sepsis in unanesthetized rats. Arch Surg 1987;122(1):86-92. (Pubitemid 17229263)
36. Cronenwett JL, Lindenauer SM. Direct measurement of arteriovenous anastomotic blood flow in the septic canine hindlimb. Surgery 1979;85(3): 275-282. (Pubitemid 10206840)
37. Guc MO, Furman BL, Parratt JR. Endotoxin-induced impairment of vasopressor and vasodepressor responses in the pithed rat. Br J Pharmacol 1990;101(4):913-919.
38. Groeneveld AB, et al. Circulating endothelin and nitrate-nitrite relate to hemodynamic and metabolic variables in human septic shock. Shock 1999;11(3): 160-166.
39. Hebert MT, Marshall JM. Direct observations of responses of mesenteric microcirculation of the rat to circulating noradrenaline. J Physiol 1985;368:393-407. (Pubitemid 16192425)
40. Tyml K, Yu J, McCormack DG. Capillary and arteriolar responses to local vasodilators are impaired in a rat model of sepsis. J Appl Physiol 1998;84(3):837-844. (Pubitemid 28110610)
41. Piepot HA, et al. Lipopolysaccharide impairs endothelial nitric oxide synthesis in rat renal arteries. Kidney Int 2000;57(6):2502-2510. (Pubitemid 30340748)
42. Hohlfeld T, et al. The contribution of tumour necrosis factor-alpha and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin. Br J Pharmacol 1995;116(8):3309-3315. (Pubitemid 26007777)
43. Van Heuven-Nolsen D, De Wildt DJ, Nijkamp FP. Disturbed adrenergic regulation of coronary flow in the guinea-pig heart after endotoxin. Eur J Pharmacol 1985;118(3): 341-345. (Pubitemid 16179859)
44. Wang SY, et al. Chronic septicemia alters alpha-adrenergic mechanisms in the coronary circulation. J Surg Res 1997;69(1): 61-66. (Pubitemid 27265828)
45. Sibelius U, et al. Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts: role of thromboxane generation. Circulation 2000;101(1):78-85. (Pubitemid 30039080)
46. Reines HD, et al. Plasma thromboxane concentrations are raised in patients dying with septic shock. Lancet 1982;2(8291):174-175. (Pubitemid 12080516)
47. Jones JJ, et al. Contractile function and myoplasmic free Ca2+ (Cam) in coronary and mesenteric arteries of endotoxemic guinea pigs. Shock 1999;11(1):64-71.
48. Fantini GA, et al. Adrenergic mechanisms contribute to alterations in regional perfusion during normotensive E. coli bacteremia. J Trauma 1989;29(9):1252-1257. (Pubitemid 19251885)
49. Mulder MF, et al. The fall of cardiac output in endotoxemic rats cannot explain all changes in organ blood flow: a comparison between endotoxin and low venous return shock. Shock 1996;5(2):135-140. (Pubitemid 126727643)
50. Yamamoto S, et al. Endothelin causes portal and pulmonary hypertension in porcine endotoxemic shock. Am J Physiol 1997;272:1239-1249.
51. Uchino S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294(7):813-818. (Pubitemid 41175724)
52. Goncalves GM, Zamboni DS, Camara NO. The role of innate immunity in septic acute kidney injuries. Shock 2010;34 Suppl 1:22-26.
53. Allman KG, et al. L-arginine augments nitric oxide production and mesenteric blood flow in ovine endotoxemia. Am J Physiol 1996;271:H1296-1301.
54. Pastor CM. Vascular hyporesponsiveness of the renal circulation during endotoxemia in anesthetized pigs. Crit Care Med 1999;27(12):2735-2740. (Pubitemid 30027190)
55. Schwartz D, et al. Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest 1997;100(2):439-448. (Pubitemid 27349092)
56. Rosengarten B, et al. Microcirculatory dysfunction in the brain precedes changes in evoked potentials in endotoxin-induced sepsis syndrome in rats. Cerebrovasc Dis 2007;23:140-147. (Pubitemid 46239154)
57. Waller J, Gardiner SM, Bennett T. Regional haemodynamic responses to acetylcholine, methoxamine, salbutamol and bradykinin during lipopolysaccharide infusion in conscious rats. Br J Pharmacol 1994;112(4):1057-1064. (Pubitemid 24245405)
58. Gunnett CA, et al. Vascular effects of LPS in mice deficient in expression of the gene for inducible nitric oxide synthase. Am J Physiol 1998;275(2 Pt 2):H416-H421. (Pubitemid 28394804)
59. Schneider F, et al. Effect of bacterial lipopolysaccharide on function of rat small femoral arteries. Am J Physiol 1994;266(1 Pt 2):H191-H198. (Pubitemid 24051508)
60. Martin CM, et al. Differential impairment of vascular reactivity of small pulmonary and systemic arteries in hyperdynamic sepsis. Am Rev Respir Dis 1993;148(1):164-172. (Pubitemid 23187237)
61. Gardiner SM, et al. Regional haemodynamic responses to infusion of lipopolysaccharide in conscious rats: effects of pre- or post-treatment with glibenclamide. Br J Pharmacol 1999;128(8):1772-1778. (Pubitemid 30011891)
62. Cameron EM, et al. Mesenteric and skeletal muscle microvascular responsiveness in subacute sepsis. Shock 1998;9(3):184-192. (Pubitemid 128463283)
63. Matsuda N, Hattori Y. Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction. J Smooth Muscle Res 2007;43(4):117-137.
64. Conway EM, Rosenberg RD. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol 1988;8(12):5588-5592.
65. Dickneite G. Antithrombin III in animal models of sepsis and organ failure. Semin Thromb Hemost 1998;24(1):61-69. (Pubitemid 28126224)
66. Machado FR, Cesar MS. Sepsis, coagulation and anticoagulants. Endocr Metab Immune Disord Drug Targets. 2010 Sep 1;10(3):204-213.
67. Flierl MA, et al. The complement anaphylatoxin C5a induces apoptosis in adrenomedullary cells during experimental sepsis. PLoS ONE 2008;3(7):e2560.
68. Rivers E, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345(19):1368-1377.
69. Ritter S, Rudiger A, Maggiorini M. Transpulmonary thermodilution derived cardiac function index identifies cardiac dysfunction in acute heart failure and septic patients: an observational study. Crit Care 2009;13(4):R133.
70. Yang CS, et al. [The prognostic value of extravascular lung water index in critically ill septic shock patients]. Zhonghua Nei Ke Za Zhi 2006;45(3):192-195.
71. Walley KR, Use of Central Venous Oxygen Saturation to Guide Therapy. Am J Respir Crit Care Med 2011 Sep 1;184(5):514-520.
72. Mikkelsen ME, et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 2009;37(5):1670-1677.
73. Gunnerson KJ, et al. Lactate versus nonlactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients. Crit Care 2006;10(1):R22.
74. Arnold RC, et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock 2009,32(1):35-39.
75. Dellinger RP, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008;34(1):17-60.
76. Vallee F, et al. Central venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock? Intensive Care Med 2008;34(12):2218-2225.
77. Groner W, et al. Orthogonal polarization spectral imaging: a new method for study of the microcirculation. Nat Med 1999;5(10):1209-1212.
78. De Backer D, et al. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002;166(1):98-104. (Pubitemid 34693970)
79. Vincent JL, De Backer D. Microvascular dysfunction as a cause of organ dysfunction in severe sepsis. Crit Care 2005;9 Suppl 4:S9-S12. (Pubitemid 41498526)